Literature DB >> 9006403

Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.

R K Brooner1, V L King, M Kidorf, C W Schmidt, G E Bigelow.   

Abstract

BACKGROUND: Major studies of psychiatric comorbidity in opioid abusers reported rates of comorbidity that far exceeded general population estimates. These studies were published more than a decade ago and reported on few women and few substance use diagnoses.
METHODS: Psychiatric and substance use comorbidity was assessed in 716 opioid abusers seeking methadone maintenance. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition diagnostic assessment was conducted 1 month after admission. Rates of psychiatric and substance use disorder were compared by gender, and associations were assessed between psychiatric comorbidity and dimensional indexes of substance use severity, psychosocial impairment, and personality traits.
RESULTS: Psychiatric comorbidity was documented in 47% of the sample (47% women and 48% men). Antisocial personality disorder (25.1%) and major depression (15.8%) were the most common diagnoses. Patients had at least 2 substance use diagnoses, most often opioid and cocaine dependence. Demographics, substance use history, and personality variables discriminated between patients with vs without comorbidity. Psychiatric comorbidity also was associated with a more severe substance use disorder.
CONCLUSIONS: Psychiatric comorbidity, especially personality and mood disorder, was common in men and women. The positive associations between psychiatric comorbidity and severity of substance use and other psychosocial problems were most consistent among those with antisocial personality.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006403     DOI: 10.1001/archpsyc.1997.01830130077015

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  195 in total

1.  Generalizability of clinical trials for cannabis dependence to community samples.

Authors:  Mayumi Okuda; Deborah S Hasin; Mark Olfson; Sharaf S Khan; Edward V Nunes; Ivan Montoya; Shang-Min Liu; Bridget F Grant; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  Pilot study of treatment for major depression among women prisoners with substance use disorder.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Psychiatr Res       Date:  2012-06-12       Impact factor: 4.791

3.  A treatment reengagement intervention for syringe exchangers.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Ken Kolodner; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2011-08-09

4.  Sex differences in prevalence and comorbidity of alcohol and drug use disorders: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Deborah A Dawson; S Patricia Chou; Bridget F Grant
Journal:  J Stud Alcohol Drugs       Date:  2012-11       Impact factor: 2.582

5.  Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data.

Authors:  Catherine E Myers; Jony Sheynin; Tarryn Balsdon; Andre Luzardo; Kevin D Beck; Lee Hogarth; Paul Haber; Ahmed A Moustafa
Journal:  Behav Brain Res       Date:  2015-09-14       Impact factor: 3.332

6.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

7.  A behavioral treatment for opioid-dependent patients with antisocial personality.

Authors:  Karin J Neufeld; Michael S Kidorf; Kenneth Kolodner; Van L King; Michael Clark; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-06-15

8.  The Harnessing Online Peer Education (HOPE) Intervention for Reducing Prescription Drug Abuse: A Qualitative Study.

Authors:  Sean D Young; Keith Heinzerling
Journal:  J Subst Use       Date:  2017-01-31

9.  Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.

Authors:  Margaret L Griffin; Dorian R Dodd; Jennifer S Potter; Lindsay S Rice; William Dickinson; Steven Sparenborg; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11-12       Impact factor: 3.829

10.  Drug abuse treatment success among needle exchange participants.

Authors:  R Brooner; M Kidorf; V King; P Beilenson; D Svikis; D Vlahov
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.